/PRNewswire/ Alora Pharmaceuticals, LLC, the parent company of Vertical Pharmaceuticals, LLC, announced today the commercial availability of Relexxii®.
The global 3D Printed Drugs Market is expected to reach a valuation of US$ 742.88 Million by 2032, with the market expanding at a stellar CAGR of 9.2% from 2022 to 2032. The target market will likely generate an estimated US$ 307.54 Million by the end of 2022. Large-scale applications in the healthcare sector along.
The global 3D Printed Drugs Market is expected to reach a valuation of US$ 742.88 Million by 2032, with the market expanding at a stellar CAGR of 9.2% from 2022 to 2032. The target market will likely generate an estimated US$ 307.54 Million by the end of 2022. Large-scale applications in the healthcare sector along.
At Apotex, he restructured the US commercial team to maximize efficiency and established procedures for identifying and executing life cycle management practices to improve profitability and market penetration.
/PRNewswire/ Piramal Pharma Limited s (NSE: PPLPHARMA) (BSE: 543635) Piramal Critical Care (PCC) business, a producer of Inhaled Anesthetics and a global.